InGeneron enables novel, safe, and evidence-based therapies that unlock the healing potential of each patient's own regenerative cells.
InGeneron has raised $1.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2024.
InGeneron's investors include Sanford Health.
InGeneron is headquartered in Houston, United States.
InGeneron enables novel, safe, and evidence-based therapies that unlock the healing potential of each patient's own regenerative cells.
InGeneron is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"InGeneron — Funding & Investors." VCBacked, March 1, 2024, https://www.vcbacked.co/company/ingeneron. Accessed August 14, 2026.
VCBacked. (2024). InGeneron — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/ingeneron
{{cite web |title=InGeneron — Funding & Investors |url=https://www.vcbacked.co/company/ingeneron |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated